Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Gas Sensing Capsule Could Uphold Gut Health

By LabMedica International staff writers
Posted on 22 Mar 2015
A novel ingestible capsule can measure the concentration of selected intestinal gases, opening new possibilities for diagnosis, treatment, and health analysis.

Developed by researchers at RMIT University (Melbourne, Australia) and Monash University (Melbourne, Australia), the capsule features bio-compatible cladding, a gas permeable membrane, gas sensor, electronic circuits such as sensor drivers, micro-controllers, wireless high-frequency transmission electronics, and a battery. Animal trials have demonstrated the effectiveness and safety of the capsules, which transmit data as they move through the gut to a handheld device such as a mobile phone, before passing out of the body.

Currently, doctors rely on indirect measurements, such as breath and fecal analysis, to gauge which gases are in the intestine. But an ingested sensor could directly analyze the gases released when bacteria ferment undigested food in the gut, such as carbon dioxide (CO2), hydrogen, methane, oxygen, and hydrogen sulphide. Supporting apps could have libraries that compare fractional gas concentrations in various states, so that the relative changes would indicate certain diseases or intestinal conditions. The study describing the capsule was published on March 12, 2015, in Trends in Biotechnology.

“A gas-sensing pill could give you a real-time glimpse into what’s going on in your gut; as the gases permeate the capsule, the sensors produce signals and digitize the data, then send it to an app,” said senior author Prof. Kourosh Kalantar-Zadeh, PHD, of RMIT. “If some organic compound like butyrate goes up, that means something is happening to the wall of the stomach, and the thing that is happening is generally not good, has to be detected, and should be addressed very quickly.”

“We know gut microorganisms produce gases as a by-product of their metabolism, but we understand very little about how that affects our health,” added Prof. Kalantar-Zadeh. “Being able to accurately measure intestinal gases could accelerate our knowledge about how specific gut microorganisms contribute to gastrointestinal disorders and food intake efficiency, enabling the development of new diagnostic techniques and treatments.”

Intestinal gases have been linked to colon cancer, irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD), and could potentially be used as key biomarkers for assessing overall health.

Related Links:

RMIT University
Monash University



Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Real-time PCR System
GentierX3 Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The AI predictive model identifies the most potent cancer killing immune cells for use in immunotherapies (Photo courtesy of Shutterstock)

AI Predicts Tumor-Killing Cells with High Accuracy

Cellular immunotherapy involves extracting immune cells from a patient's tumor, potentially enhancing their cancer-fighting capabilities through engineering, and then expanding and reintroducing them into the body.... Read more

Microbiology

view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.